Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP Due to Carton Label Mix-Up
The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.
Research from, Oxford's Com-Cov study highlights how mixing vaccine brands during follow-up covid vaccinations increases the risk of mild to moderate side effects.